⌘K
Loading ticker…
As of 2026-08-24, Inhibikase Therapeutics, Inc. Common Stock (IKT) has a 3-month relative strength percentile of 93 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 65. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.4%, relative volume 1.42×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
IKT is in a stage 2 uptrend, week 8. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 16.5% / 36.2%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
IKT is held by 10 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $958K notional. Top 3 carry $1M.
Held by 18 ETFs · $14M across latest filings · largest weight 0.19% (IBRN).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $9K |
| — |
| URTY | 0.00% | $7K | — |
| UWM | 0.00% | $7K | — |
| HDG | 0.00% | $175 | — |
| RB | 0.00% | $54 | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IKT Jan avg: 30.41% median: 7.17% win: 50% σ: 78.56% n: 4 2022-04-12 → 2026-07-31 | IKT Feb avg: 3.57% median: 3.00% win: 75% σ: 26.60% n: 4 2022-04-12 → 2026-07-31 | IKT Mar avg: -8.46% median: -7.89% win: 0% σ: 7.82% n: 4 2022-04-12 → 2026-07-31 | IKT Apr avg: -9.51% median: -15.02% win: 40% σ: 17.50% n: 5 2022-04-12 → 2026-07-31 | IKT May avg: 2.92% median: -7.41% win: 40% σ: 19.58% n: 5 2022-04-12 → 2026-07-31 | IKT Jun avg: -10.54% median: -12.55% win: 20% σ: 18.69% n: 5 2022-04-12 → 2026-07-31 | IKT Jul avg: -2.16% median: 7.39% win: 60% σ: 21.12% n: 5 2022-04-12 → 2026-07-31 | IKT Aug avg: 1.47% median: 6.10% win: 50% σ: 15.94% n: 4 2022-04-12 → 2026-07-31 (current) | IKT Sep avg: -13.29% median: -8.57% win: 0% σ: 11.87% n: 4 2022-04-12 → 2026-07-31 | IKT Oct avg: 8.48% median: -12.20% win: 25% σ: 58.58% n: 4 2022-04-12 → 2026-07-31 | IKT Nov avg: 0.76% median: 4.63% win: 75% σ: 15.80% n: 4 2022-04-12 → 2026-07-31 | IKT Dec avg: 16.06% median: 23.09% win: 75% σ: 24.98% n: 4 2022-04-12 → 2026-07-31 |